PRASHANTH ANUMANDLA: Open Payments
NPI 1831208966 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,159 in 35 payments from 7 companies in 2025. Trend: 2023 $3,843 · 2024 $2,460 · 2025 $2,159
Food & beverage: $1,289Travel & lodging: $870
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 9 | $1,318 |
| Actelion Pharmaceuticals US, Inc. | 5 | $264 |
| Abbott Laboratories | 11 | $232 |
| Amgen Inc. | 4 | $163 |
| BridgeBio Pharma, Inc. | 4 | $138 |
| AstraZeneca Pharmaceuticals LP | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: Barostim Neo System, CARDIOMEMS, UPTRAVI, REPATHA, Attruby, OPSUMIT, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, WAINUA.
Industry payments across TX — which companies pay providers there.
